| ||||||||||||||
|
|
|||||||||||||

Departments of *Anesthesiology and Critical Care Medicine and
Surgery, Leopold-Franzens-University, Innsbruck, Austria
Address correspondence to Claus Raedler, MD, Department of Anesthesiology and Critical Care Medicine, Leopold-Franzens-University, Anichstrasse 35, 6020 Innsbruck, Austria. Address reprints to Karl H. Lindner, MD, Department of Anesthesiology and Critical Care Medicine, Leopold-Franzens-University, Anichstrasse 35, 6020 Innsbruck, Austria. Address e-mail to claus.raedler{at}uibk.ac.at
In a porcine model of uncontrolled hemorrhagic shock, we evaluated the effects of vasopressin versus an equal volume of saline placebo versus fluid resuscitation on hemodynamic variables and short-term survival. Twenty-one anesthetized pigs were subjected to severe liver injury. When mean arterial blood pressure was <20 mm Hg and heart rate decreased, pigs randomly received either vasopressin IV (0.4 U/kg; n = 7), an equal volume of saline placebo (n = 7), or fluid resuscitation (1000 mL each of lactated Ringers solution and hetastarch; n = 7). Thirty minutes after intervention, surviving pigs were fluid resuscitated while bleeding was surgically controlled. Mean (± SEM) arterial blood pressure 5 min after the intervention was significantly (P < 0.05) higher after vasopressin than with saline placebo or fluid resuscitation (58 ± 9 versus 7 ± 3 versus 32 ± 6 mm Hg, respectively). Vasopressin improved abdominal organ blood flow but did not cause further blood loss (vasopressin versus saline placebo versus fluid resuscitation 10 min after intervention, 1343 ± 60 versus 1350 ± 22 versus 2536 ± 93 mL, respectively; P < 0.01). Seven of 7 vasopressin pigs survived until bleeding was controlled and 60 min thereafter, whereas 7 of 7 saline placebo and 7 of 7 fluid resuscitation pigs died (P < 0.01). We conclude that vasopressin, but not saline placebo or fluid resuscitation, significantly improves short-term survival during uncontrolled hemorrhagic shock.
IMPLICATIONS: Although IV fluid administration is the mainstay of nonsurgical management of trauma patients with uncontrolled hemorrhagic shock, the efficacy of this strategy has been discussed controversially. In this animal model of severe liver trauma with uncontrolled hemorrhagic shock, vasopressin, but not saline placebo or fluid resuscitation, improved short-term survival.
This article has been cited by other articles:
![]() |
S. L. M. Mitchell and J.M. Hunter Vasopressin and its antagonists: what are their roles in acute medical care? Br. J. Anaesth., August 1, 2007; 99(2): 154 - 158. [Full Text] [PDF] |
||||
![]() |
J. V. Roth The use of vasopressin bolus to treat refractory hypotension secondary to reperfusion during orthotopic liver transplantation. Anesth. Analg., July 1, 2006; 103(1): 261 - 261. [Full Text] [PDF] |
||||
![]() |
W. G. Voelckel, G. Klima, A. C. Krismer, C. Haslinger, K. H. Stadlbauer, V. Wenzel, and A. von Goedecke Signs of Inflammation After Sciatic Nerve Block in Pigs Anesth. Analg., December 1, 2005; 101(6): 1844 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Stadlbauer, V. Wenzel, A. C. Krismer, W. G. Voelckel, and K. H. Lindner Vasopressin During Uncontrolled Hemorrhagic Shock: Less Bleeding Below the Diaphragm, More Perfusion Above Anesth. Analg., September 1, 2005; 101(3): 830 - 832. [Full Text] [PDF] |
||||
![]() |
R. M. Sharma and R. Setlur Vasopressin in Hemorrhagic Shock Anesth. Analg., September 1, 2005; 101(3): 833 - 834. [Abstract] [Full Text] [PDF] |
||||
|